EE04963B1 - 8,8a-dihdroindeno[1,2-d]tiasooli derivaadid, mille 2-asendis on sulfoonamido- v?i sulfonorhma sisaldav asendaja, nende valmistamismeetod ja kasutamine ravimitena - Google Patents

8,8a-dihdroindeno[1,2-d]tiasooli derivaadid, mille 2-asendis on sulfoonamido- v?i sulfonorhma sisaldav asendaja, nende valmistamismeetod ja kasutamine ravimitena

Info

Publication number
EE04963B1
EE04963B1 EEP200200467A EEP200200467A EE04963B1 EE 04963 B1 EE04963 B1 EE 04963B1 EE P200200467 A EEP200200467 A EE P200200467A EE P200200467 A EEP200200467 A EE P200200467A EE 04963 B1 EE04963 B1 EE 04963B1
Authority
EE
Estonia
Prior art keywords
preparation
substituent
sulphonorma
droindeno
sulphonamido
Prior art date
Application number
EEP200200467A
Other languages
English (en)
Estonian (et)
Inventor
Jaehne Gerhard
Lang Hans-Jochen
Gossel Matthias
Bickel Martin
Original Assignee
Aventis Pharma Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland Gmbh filed Critical Aventis Pharma Deutschland Gmbh
Publication of EE200200467A publication Critical patent/EE200200467A/xx
Publication of EE04963B1 publication Critical patent/EE04963B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Indole Compounds (AREA)
EEP200200467A 2000-02-26 2001-02-13 8,8a-dihdroindeno[1,2-d]tiasooli derivaadid, mille 2-asendis on sulfoonamido- v?i sulfonorhma sisaldav asendaja, nende valmistamismeetod ja kasutamine ravimitena EE04963B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10009311 2000-02-26
PCT/EP2001/001553 WO2001062747A1 (de) 2000-02-26 2001-02-13 8,8a-dihydro-indeno[1,2-d]thiazol-derivate, die in 2-stellung einen substituenten mit einer sulfonamidstruktur oder sulfonstruktur tragen; verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
EE200200467A EE200200467A (et) 2003-12-15
EE04963B1 true EE04963B1 (et) 2008-02-15

Family

ID=7632679

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200467A EE04963B1 (et) 2000-02-26 2001-02-13 8,8a-dihdroindeno[1,2-d]tiasooli derivaadid, mille 2-asendis on sulfoonamido- v?i sulfonorhma sisaldav asendaja, nende valmistamismeetod ja kasutamine ravimitena

Country Status (29)

Country Link
US (2) US6352987B2 (cs)
EP (1) EP1261593B1 (cs)
JP (1) JP4950405B2 (cs)
KR (1) KR100763214B1 (cs)
CN (1) CN1173959C (cs)
AT (1) ATE248155T1 (cs)
AU (2) AU4413601A (cs)
BR (1) BR0108631A (cs)
CA (1) CA2400704C (cs)
CZ (1) CZ301253B6 (cs)
DE (1) DE50100558D1 (cs)
DK (1) DK1261593T3 (cs)
EE (1) EE04963B1 (cs)
ES (1) ES2206412T3 (cs)
HK (1) HK1052515B (cs)
HR (1) HRP20020687B1 (cs)
HU (1) HU229137B1 (cs)
IL (1) IL151460A (cs)
MX (1) MXPA02007025A (cs)
NO (1) NO323400B1 (cs)
NZ (1) NZ520981A (cs)
PL (1) PL202763B1 (cs)
PT (1) PT1261593E (cs)
RS (1) RS49933B (cs)
RU (1) RU2263113C2 (cs)
SI (1) SI1261593T1 (cs)
SK (1) SK285571B6 (cs)
WO (1) WO2001062747A1 (cs)
ZA (1) ZA200206580B (cs)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US7261482B2 (en) * 2004-01-21 2007-08-28 Silverbrook Research Pty Ltd Photofinishing system with slitting mechanism
US20080125403A1 (en) 2004-04-02 2008-05-29 Merck & Co., Inc. Method of Treating Men with Metabolic and Anthropometric Disorders
MX354786B (es) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CA2930674A1 (en) 2008-06-04 2009-12-10 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
CA2730603C (en) 2008-07-16 2019-09-24 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
CN102264228A (zh) 2008-10-22 2011-11-30 默沙东公司 用于抗糖尿病药的新的环状苯并咪唑衍生物
US8329914B2 (en) 2008-10-31 2012-12-11 Merck Sharp & Dohme Corp Cyclic benzimidazole derivatives useful as anti-diabetic agents
CA2786314A1 (en) 2010-02-25 2011-09-01 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
EA201690035A1 (ru) 2011-02-25 2016-05-31 Мерк Шарп Энд Домэ Корп. Новые циклические производные азабензимидазола, используемые в качестве антидиабетических агентов
WO2012118972A2 (en) 2011-03-01 2012-09-07 Synegy Pharmaceuticals Inc. Process of preparing guanylate cyclase c agonists
KR20150036245A (ko) 2012-08-02 2015-04-07 머크 샤프 앤드 돔 코포레이션 항당뇨병 트리시클릭 화합물
EP2958562B1 (en) 2013-02-22 2025-09-10 Merck Sharp & Dohme LLC Antidiabetic bicyclic compounds
EP2970119B1 (en) 2013-03-14 2021-11-03 Merck Sharp & Dohme Corp. Novel indole derivatives useful as anti-diabetic agents
AU2014235215A1 (en) 2013-03-15 2015-10-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
JP2016514670A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
CN113388007A (zh) 2013-06-05 2021-09-14 博士医疗爱尔兰有限公司 鸟苷酸环化酶c的超纯激动剂、制备和使用所述激动剂的方法
WO2015051496A1 (en) 2013-10-08 2015-04-16 Merck Sharp & Dohme Corp. Antidiabetic tricyclic compounds
WO2018106518A1 (en) 2016-12-06 2018-06-14 Merck Sharp & Dohme Corp. Antidiabetic heterocyclic compounds
WO2018118670A1 (en) 2016-12-20 2018-06-28 Merck Sharp & Dohme Corp. Antidiabetic spirochroman compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507868A (en) * 1968-10-21 1970-04-21 Sandoz Ag Imidazo(2,1-b)thiazoles and thiazolo(3,2-a)pyrimidines
DE2640358A1 (de) * 1976-09-08 1978-03-16 Hoechst Ag Thiazolidinderivate und verfahren zu ihrer herstellung
CA1292226C (en) * 1986-01-16 1991-11-19 Terumi Hachiya Indenothiazole derivative and process for preparing the same
DE19831878C2 (de) * 1998-07-17 2001-05-17 Aventis Pharma Gmbh Polycyclische Thiazolidin-2-yliden Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19844547C2 (de) * 1998-09-29 2002-11-07 Aventis Pharma Gmbh Polycyclische Dihydrothiazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19908533A1 (de) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Polycyclische Thiazol-Systeme, Verfahren zu ihrer Herstellung und Arzneimittel enthaltend diese Verbindungen
CZ2001170A3 (cs) * 1999-07-03 2001-06-13 Aventis Pharma Gmbh Polycyklické thiazolidin-2-ylidenaminy, způsob jejich přípravy a léčivo, které je obsahuje
CZ20011111A3 (cs) * 1999-09-16 2001-07-11 Aventis Pharma Deutschland Gmbh Deriváty indeno-, nafto- a benzocyklohepťadihydrothiazolu, jejich příprava a použití jako anorektická léčiva

Also Published As

Publication number Publication date
HRP20020687B1 (hr) 2011-01-31
SI1261593T1 (en) 2004-02-29
US20010039278A1 (en) 2001-11-08
CZ301253B6 (cs) 2009-12-23
EE200200467A (et) 2003-12-15
NO20023977D0 (no) 2002-08-21
MXPA02007025A (es) 2003-03-27
SK12252002A3 (sk) 2003-03-04
CN1173959C (zh) 2004-11-03
HK1052515A1 (en) 2003-09-19
NO20023977L (no) 2002-10-18
RS49933B (sr) 2008-09-29
EP1261593B1 (de) 2003-08-27
JP4950405B2 (ja) 2012-06-13
KR100763214B1 (ko) 2007-10-08
HUP0300304A3 (en) 2004-10-28
RU2263113C2 (ru) 2005-10-27
KR20020079897A (ko) 2002-10-19
HU229137B1 (en) 2013-08-28
CA2400704A1 (en) 2001-08-30
AU2001244136B2 (en) 2005-04-14
PL202763B1 (pl) 2009-07-31
BR0108631A (pt) 2002-12-03
US6444669B1 (en) 2002-09-03
WO2001062747A1 (de) 2001-08-30
DE50100558D1 (de) 2003-10-02
EP1261593A1 (de) 2002-12-04
ES2206412T3 (es) 2004-05-16
CA2400704C (en) 2008-11-04
CN1406234A (zh) 2003-03-26
RU2002125673A (ru) 2004-01-10
US6352987B2 (en) 2002-03-05
NZ520981A (en) 2004-08-27
SK285571B6 (sk) 2007-04-05
YU56402A (sh) 2005-11-28
ATE248155T1 (de) 2003-09-15
PL357195A1 (en) 2004-07-26
US20020103231A1 (en) 2002-08-01
HRP20020687A2 (en) 2004-12-31
PT1261593E (pt) 2004-01-30
CZ20022861A3 (cs) 2002-11-13
AU4413601A (en) 2001-09-03
HK1052515B (zh) 2005-04-22
HUP0300304A2 (hu) 2003-06-28
IL151460A (en) 2008-08-07
DK1261593T3 (da) 2003-12-01
NO323400B1 (no) 2007-04-23
ZA200206580B (en) 2003-05-15
JP2003531117A (ja) 2003-10-21

Similar Documents

Publication Publication Date Title
EE04963B1 (et) 8,8a-dihdroindeno[1,2-d]tiasooli derivaadid, mille 2-asendis on sulfoonamido- v?i sulfonorhma sisaldav asendaja, nende valmistamismeetod ja kasutamine ravimitena
NO20023978L (no) 8,8A-dihydro-indeno(1,2-D)tiazolderivater, substituert i posisjon 8A, en fremgangsmåte for deres fremstilling og deresanvendelse som legemidler, for eksempel anoreksimidler
PT1140944E (pt) Derivados de epotilona e sua utilizacao como agentes antitumorais
BRPI0407387A (pt) Derivados de hexahidro-pirazino[1,2-a]pirimidin-4,7-diona substituìdos por nitrogênio, processos para a sua preparação e sua aplicação com medicamento
BR0207278A (pt) Derivados de ftalazinona-piperidina como inibidores de pde4
EA200300392A1 (ru) Производные пиперазина с мостиковой связью
BR0210746A (pt) Derivados de 6-'2-(fosfonometóxi)alcóxi-pirimidina tendo atividade antiviral
BR0213990A (pt) Derivados de piperazina tendo atividade antagonìstica de sst1
EP1671957A4 (en) THIADIAZOLINDERIVATE
BR0008510A (pt) Sistemas policìclicos de 2-amino-tiazol, processo para a sua preparação e medicamento contendo estes compostos
BRPI0415034A (pt) derivados de aminopiridina como inibidores de não-sintase induzìveis
BR9805437A (pt) Derivados de benzocicloalquenos heterocìclicos, processo para fabricação de derivados de benzocicloalquenos heterocìclicos e uso de derivados de benzocicloalquenos heterocìclicos.
BR0317693A (pt) Derivados de epotilona
PT1183247E (pt) Sistemas tiazole policiclicos e sua utilizacao como anorecticos
GEP20063758B (en) Benzothia(Dia)Zine Derivatives and Method for Their Use as AMPA Modulators
ATE261938T1 (de) Benzolsulfonamid-derivate und ihre verwendung
TR200100475T2 (tr) N-İkameli azabisikloheptan türevlerinin üretimleri ve kullanımları.
EE200200465A (et) Asendatud 8,8a-dihüdro-3aH-indeno[1,2-d]tiasoolid, nende valmistamismeetod ja kasutamine ravimitena
UY26347A1 (es) Derivados de bencimidazol sustituidos con arilsulfonamida, procedimiento para su preparación y su empleo como medicamentos.
BR9915898A (pt) Compostos, composição farmacêutica, e, utilização de um composto
UY26346A1 (es) Derivados de bencimidazol sustituidos, procedimiento para preparación y su empleo como medicamentos.
UY26433A1 (es) Derivados de bencimidazol sustituidos con carboxamida, su preparación y su empleo como medicamentos
DOP2002000362A (es) Nuevas arilsulfonamidas como agentes antivirales.
ECSP982773A (es) Derivados heterociclicos de benzocicloalqueno y procedimiento para su fabricacion
ECSP003666A (es) Derivados de bencimidazol sustituidos con arilsulfonamida, procedimiento para su preparacion y su empleo como medicamentos

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20150213